166 related articles for article (PubMed ID: 34575993)
1. A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A
Viczjan G; Erdei T; Ovari I; Lampe N; Szekeres R; Bombicz M; Takacs B; Szilagyi A; Zsuga J; Szilvassy Z; Juhasz B; Gesztelyi R
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575993
[TBL] [Abstract][Full Text] [Related]
2. An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A
Szabo AM; Erdei T; Viczjan G; Kiss R; Zsuga J; Papp C; Pinter A; Juhasz B; Szilvassy Z; Gesztelyi R
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212849
[TBL] [Abstract][Full Text] [Related]
3. FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.
Erdei T; Szabo AM; Lampe N; Szabo K; Kiss R; Zsuga J; Papp C; Pinter A; Szentmiklosi AJ; Szilvassy Z; Juhasz B; Gesztelyi R
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200192
[TBL] [Abstract][Full Text] [Related]
4. The guinea pig atrial A1 adenosine receptor reserve for the direct negative inotropic effect of adenosine.
Kiss Z; Pak K; Zsuga J; Juhasz B; Varga B; Szentmiklosi AJ; Haines DD; Tosaki A; Gesztelyi R
Gen Physiol Biophys; 2013 Sep; 32(3):325-35. PubMed ID: 23817640
[TBL] [Abstract][Full Text] [Related]
5. The surmountable effect of FSCPX, an irreversible A(1) adenosine receptor antagonist, on the negative inotropic action of A(1) adenosine receptor full agonists in isolated guinea pig left atria.
Gesztelyi R; Kiss Z; Wachal Z; Juhasz B; Bombicz M; Csepanyi E; Pak K; Zsuga J; Papp C; Galajda Z; Branzaniuc K; Porszasz R; Szentmiklosi AJ; Tosaki A
Arch Pharm Res; 2013 Mar; 36(3):293-305. PubMed ID: 23456693
[TBL] [Abstract][Full Text] [Related]
6. A novel irreversible antagonist of the A1-adenosine receptor.
Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
[TBL] [Abstract][Full Text] [Related]
7. Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist.
He W; Wilder T; Cronstein BN
Br J Pharmacol; 2013 Nov; 170(6):1167-76. PubMed ID: 23962057
[TBL] [Abstract][Full Text] [Related]
8. Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.
Zsuga J; Erdei T; Szabó K; Lampe N; Papp C; Pinter A; Szentmiklosi AJ; Juhasz B; Szilvássy Z; Gesztelyi R
Molecules; 2017 May; 22(5):. PubMed ID: 28534854
[TBL] [Abstract][Full Text] [Related]
9. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
[TBL] [Abstract][Full Text] [Related]
10. Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis.
Antonioli L; Fornai M; Colucci R; Awwad O; Ghisu N; Tuccori M; Del Tacca M; Blandizzi C
Eur J Pharmacol; 2011 Jan; 650(2-3):639-49. PubMed ID: 21034735
[TBL] [Abstract][Full Text] [Related]
11. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
13. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormones decrease the affinity of 8-cyclopentyl-1,3-dipropylxanthine (CPX), a competitive antagonist, for the guinea pig atrial A(1) adenosine receptor.
Gesztelyi R; Kiss Z; Zsuga J; Pak K; Papp C; Galajda Z; Branzaniuc K; Szentmiklosi AJ; Tosaki A
Gen Physiol Biophys; 2012 Dec; 31(4):389-400. PubMed ID: 23255665
[TBL] [Abstract][Full Text] [Related]
15. [A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response].
Gros L; Paturel C; Perrot I; Bensussan A; Eliaou JF; Bastid J; Bonnefoy N
Med Sci (Paris); 2020 Feb; 36(2):112-115. PubMed ID: 32129745
[No Abstract] [Full Text] [Related]
16. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
[TBL] [Abstract][Full Text] [Related]
17. The effect of adenosine deaminase inhibition on the A1 adenosinergic and M2 muscarinergic control of contractility in eu- and hyperthyroid guinea pig atria.
Pak K; Zsuga J; Kepes Z; Erdei T; Varga B; Juhasz B; Szentmiklosi AJ; Gesztelyi R
Naunyn Schmiedebergs Arch Pharmacol; 2015 Aug; 388(8):853-68. PubMed ID: 25877465
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and use of FSCPX, an irreversible adenosine A1 antagonist, as a 'receptor knock-down' tool.
van Muijlwijk-Koezen JE; Timmerman H; van der Sluis RP; van de Stolpe AC; Menge WM; Beukers MW; van der Graaf PH; de Groote M; IJzerman AP
Bioorg Med Chem Lett; 2001 Mar; 11(6):815-8. PubMed ID: 11277527
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.
Fausther M; Lecka J; Soliman E; Kauffenstein G; Pelletier J; Sheung N; Dranoff JA; Sévigny J
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(4):G447-59. PubMed ID: 22135310
[TBL] [Abstract][Full Text] [Related]
20. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
